Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 USD | -1.69% | +14.70% | -3.65% |
Financials (USD)
Sales 2023 | 1.7M | Sales 2024 * | 36.7M | Capitalization | 1.44B |
---|---|---|---|---|---|
Net income 2023 | -208M | Net income 2024 * | -175M | EV / Sales 2023 | 660 x |
Net cash position 2023 * | 299M | Net cash position 2024 * | 589M | EV / Sales 2024 * | 23.2 x |
P/E ratio 2023 |
-5.37
x | P/E ratio 2024 * |
-7.2
x | Employees | 402 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 3.8% |
Latest transcript on Autolus Therapeutics plc
1 day | +6.62% | ||
1 week | +14.70% | ||
Current month | +3.42% | ||
1 month | -9.15% | ||
3 months | +19.79% | ||
6 months | +120.82% | ||
Current year | -3.65% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Chief Executive Officer | 59 | 14-09-30 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
John Johnson
CHM | Chairman | 66 | 21-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 6.205 | +6.62% | 1 264 070 |
24-03-15 | 5.82 | +2.11% | 2,012,513 |
24-03-14 | 5.7 | +4.01% | 2,952,583 |
24-03-13 | 5.48 | +1.67% | 1,097,580 |
24-03-12 | 5.39 | -0.37% | 1,503,170 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.65% | 1.44B | |
+1.10% | 106B | |
+9.29% | 103B | |
-3.00% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.20% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |